
|Slideshows|August 28, 2017
Update on Stroke Risks
Author(s)Mark L. Fuerst
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome
2
FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy
3
NLX-112 Shows Safety and Tolerability in Phase 2a Parkinson Trial, Supporting Further Development
4
Levacetylleucine Meets Primary and Secondary End Points in Phase 3 Ataxia-Telangiectasia Study
5


























